Adding continuous infusion therapies after bilateral subthalamic deep brain stimulation in advanced Parkinson’s disease: clinical outcomes and quality of life assessment in a case series
Neurologia i Neurochirurgia Polska · 2026
DOI: 10.5603/pjnns.107157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurologia i Neurochirurgia Polska, 2026. Verfasst von Stanisław Szlufik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland. stanislaw.szlufik@wum.edu.pl. Hauptthemen laut MEDLINE: Parkinson Disease, Deep Brain Stimulation, Quality of Life, Levodopa. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily presents with motor and non-motor symptoms and significantly affects patients’ quality of life (QoL). Although bilateral subthalamic nucleus deep brain stimulation (STN DBS) is recognized as an effective advanced treatment (AT), disease progression may lead to diminished therapeutic outcomes, with recurrence of motor complications, including dyskinesia and fluctuations. This study evaluates the clinical effectiveness and QoL outcomes associated with adding a second advanced therapy (either levodopa-carbidopa intestinal gel [LCIG] or continuous subcutaneous apomorphine infusion [CSAI]) to bilateral STN DBS in six patients experiencing symptom recurrence despite optimized stimulation settings and oral pharmacotherapy. Clinical assessments included motor performance (UPDRS part III), medication dosage (LEDD), electrode positioning using Lead-DBS software, and patient-reported QoL outcomes (EQ- -5D, PDQ-39, PDSS-1, and VAS scales). Four patients demonstrated motor improvement following the introduction of dual therapy. Combined therapies effectively managed refractory symptoms, reduced medication dosages, and significantly enhanced patients’ quality of life. This study highlights the clinical potential of integrating multiple advanced therapeutic approaches in managing complex cases of advanced Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland. stanislaw.szlufik@wum.edu.pl.
- Department of Neurosurgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. stanislaw.szlufik@wum.edu.pl.
- Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.
- Department of Neurosurgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
ORCID-Profile: Stanisław Szlufik, Łukasz Milanowski, Tomasz Mandat, Dariusz Koziorowski
Zitieren
APA
Szlufik, S., Jaros, K., Milanowski, Ł., Mandat, T., & Koziorowski, D. (2026). Adding continuous infusion therapies after bilateral subthalamic deep brain stimulation in advanced Parkinson’s disease: clinical outcomes and quality of life assessment in a case series. Neurologia i Neurochirurgia Polska. https://doi.org/10.5603/pjnns.107157
Vancouver
Szlufik S, Jaros K, Milanowski Ł, Mandat T, Koziorowski D. Adding continuous infusion therapies after bilateral subthalamic deep brain stimulation in advanced Parkinson’s disease: clinical outcomes and quality of life assessment in a case series. Neurologia i Neurochirurgia Polska. 2026. doi:10.5603/pjnns.107157
BibTeX
@article{Szlufik2026,
author = {Szlufik, Stanisław and Jaros, Karolina and Milanowski, Łukasz and Mandat, Tomasz and Koziorowski, Dariusz},
title = {Adding continuous infusion therapies after bilateral subthalamic deep brain stimulation in advanced Parkinson’s disease: clinical outcomes and quality of life assessment in a case series},
journal = {Neurologia i Neurochirurgia Polska},
year = {2026},
doi = {10.5603/pjnns.107157}
}
EUVIMED